Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock

Author: Schefold Joerg C.   Zeden Jan-Philip   Pschowski Rene   Hammoud Ben   Fotopoulou Christina   Hasper Dietrich   Fusch Gerhard   Haehling Stephan Von   Volk Hans-Dieter   Meisel Christian   Schütt Christine   Reinke Petra  

Publisher: Informa Healthcare

ISSN: 0036-5548

Source: Scandinavian Journal of Infectious Diseases, Vol.42, Iss.3, 2010-02, pp. : 164-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract